Clinical trial
Characteristics of Immunogenicity Against SARS-CoV-2 in the Community With Home-quarantined Covid-19 Patients in Ho Chi Minh City, Vietnam
NCT05094635 is registered in ClinicalTrials.gov with University of Medicine and Pharmacy at Ho Chi Minh City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characteristics of Immunogenicity Against SARS-CoV-2 in the Community With Home-quarantined Covid-19 Patients in Ho Chi Minh City, Vietnam
- Lead sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2021
- Completion date
- May 1, 2022
- Enrollment
- 772 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, vaccine reaction